SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding -- Ignore unavailable to you. Want to Upgrade?


To: Dr. Voodoo who wrote (4929)3/23/2020 2:46:14 PM
From: elmatador  Read Replies (1) | Respond to of 13800
 
Steve Bannon: We Need A "Full Shutdown" Right Now; "Go Full Hammer On The Virus"
realclearpolitics.com



To: Dr. Voodoo who wrote (4929)3/24/2020 5:58:48 AM
From: elmatador  Read Replies (2) | Respond to of 13800
 
Sawadee krup !

Perfect setting to test theory that Covid-19 will be destroyed by hot and humid weather.

Soaking rain precedes late spring, early summer warmth later this weekParts of the area will hit 80° by Saturday afternoon.


wsls.com

After an unusually mild winter across the nation, forecasters are now calling for a substantially warmer-than-normal spring.

The National Weather Service, AccuWeather and the Weather Company, in rare lockstep agreement, are all predicting above-average temperatures into June.

Abnormally warm spring expected over entire U.S., according to NOAA and others



National Weather Service spring temperature forecast.

By Jason Samenow

March 20
After an unusually mild winter across the nation, forecasters are now calling for a substantially warmer-than-normal spring.

The National Weather Service, AccuWeather and the Weather Company, in rare lockstep agreement, are all predicting above-average temperatures into June.

“There is almost no part of the country that we are predicting to be below normal in any of the three months, which is unusual,” said AccuWeather chief executive Joel Myers in AccuWeather’s outlook published Thursday. “This may be a first."



AccuWeather's spring temperature forecast. (AccuWeather)
The National Weather Service’s outlook, released Thursday, conveyed the same message: “No part of the country is favored to experience below-average temperatures this spring.”

The Weather Company’s outlook for April through June, issued March 12, is headlined: “Widespread Warmth Across U.S.”


Weather Company spring temperature forecast (Weather.com)
Hues of orange, signaling various degrees of anomalous warmth, cover the maps released by these three organizations. While they agree most of the nation, if not its entirety, will be warmer than average, they do differ in region-to-region predictions.

The Weather Service and AccuWeather both forecast the strongest warm signal in the eastern United States and along the West Coast, with a weaker signal in the middle of the nation.

The Weather Company’s outlook, however, calls for the greatest chance of above-normal temperatures from the West Coast through the Midwest.

The forecast for a warm spring, the Weather Company’s outlook said, is in part due to the abnormally strong polar vortex, which has bottled up frigid air over the Arctic rather than allowing it to spill south. The vortex typically breaks down in early spring.

[ The demise of the polar vortex could spell weather surprises this spring]

The Weather Company’s chief meteorologist, Todd Crawford, also noted in the outlook that cooling ocean temperatures in the tropical Pacific often support warmer-than-normal conditions heading into summer over the Lower 48 states.

Matt Rogers, a long-range forecaster for the Commodity Weather Group and a Capital Weather Gang contributor, said he agreed with the general idea of a warm spring across the nation but cautioned the West may see average to cooler than average conditions due to the continuation of a stormy pattern that has recently brought beneficial rain and snow to California.

Rogers also said there are signs the polar vortex is weakening, which could allow for some cooler weather in the central and eastern United States in the coming weeks.

“I agree with them [the other outlooks] in spirit overall, but I do need to think we need to watch for some cooler volatility during the front half of April,” Rogers said.

The forecast for warmer-than-average weather in the coming months follows a winter that ranked as the sixth-warmest on record for the Lower 48 and a premature start to spring in many areas. According to the USA National Phenology Network, which tracks the blooming of plants, leaves emerged on trees three to four weeks early in parts of the southern and eastern United States.

[ Coronavirus may have a seasonal cycle, but that doesn’t mean it will go away this summer, experts warn]

While factors such as the strength of the polar vortex and ocean and atmosphere cycles, such as El Niño, play a large role in a given season’s weather, the long-term increase in average temperatures due to human-caused climate change are increasing the likelihood of abnormal warmth.

There is a relatively remote possibility that the warmer than average spring into the early summer could help slow the spread of coronavirus, if some preliminary analyses that have found or projected drops in virus transmission at higher temperatures, prove correct. However, these analyses have not been peer-reviewed, and the virus has been spreading in parts of the United States that have warm weather, including Florida, as well as warm international areas, including the Philippines. In recent days, the virus has also made inroads in South Africa and India, two countries with mild average temperatures.

Andrew Freedman contributed reporting.


Jason SamenowJason Samenow is The Washington Post’s weather editor and Capital Weather Gang's chief meteorologist. He earned a master's degree in atmospheric science and spent 10 years as a climate change science analyst for the U.S. government. He holds the Digital Seal of Approval from the National Weather Association. Follow



To: Dr. Voodoo who wrote (4929)3/30/2020 2:39:18 AM
From: elmatador1 Recommendation

Recommended By
DinoNavarre

  Read Replies (1) | Respond to of 13800
 
Germany industry will benefit in a post-Covid-19 world. Forget BMW and Mercedes. Think medical devices' market

healthcare spending takes up around 11.3% of Germany’s GDP.

5 things to know about Germany’s gesund medical device market
By Chloe Kent 9 AUGUST 2019

Thanks to a global reputation of top class products and a well regulated environment, the words ‘Made in Germany’ have become synonymous with quality and innovation. We hone in on five reasons why Germany’s medical device market is the strongest in Europe.

Devices made in Germany benefit from a distinguished reputation and a guarantee of quality. Credit:

As people around the world live longer, healthier lives, the demand for innovations in medical technology is skyrocketing.

In Europe and internationally, devices made in Germany benefit from a distinguished reputation and a guarantee of quality. But what makes the German market tick?

SIMEON Medical managing director Dr Markus Keussen says: “Medical treatment in Germany reaches from basic treatment to high end, computerized medical care. The German market is characterised by fair competition, and offers a stable economic, political and regulatory environment.

“We benefit from high transparency regarding customers’ decisions and premium suppliers in mechanics, electronics and software. Outstanding research facilities and key-opinion leaders are available due to excellent medical schools and universities. We can thus rely on a highly qualified workforce with engineers and medical specialists.”

A well-built infrastructure
Germany’s medical device sector is the largest in Europe and the third largest in the world, taking up 10.2% of global medical tech production after the US (39.6%) and China (11.1%).

In 2015 it reached €27.6bn in sales, €17.6bn of which was in exports.

The industry thrives in part due to the sturdy infrastructure underpinning it – more than 99% of Germany’s 82 million residents have health insurance, and healthcare spending takes up around 11.3% of Germany’s GDP. This means that when a manufacturer develops a device in Germany and markets it to German citizens, the pathways are in place to enable it to reach patients and make a difference to their lives.


Medical device companies can also receive grants from the Kreditanstalt für Wiederaufbau (KfW) to support their business and can apply for government funding for many research projects.

A series of clustering programmes are in place in Germany, such as the European Cluster Excellence Initiative and the go-cluster initiative, which incentivise companies to position themselves among the 100 innovation clusters across the country to foster collaboration and innovation between manufacturers. Approximately 130,500 employees work for around 1,200 manufacturers in Germany.

The country’s central location in Europe also puts Germany in the ideal location to export product across the continent, with 41% of German medical technology export going to EU member states and another 10% to other European countries. A further 18% of exports are shipped to North America and Asia.

Vibrant SME sceneThe German medical devices industry is made up almost entirely of small and medium sized enterprises (SMEs), with SMEs having a 91.5% share of the market.

The SME-centric market for German medical technologies offers flexibility to innovate where the bigger American or Japanese corporations must focus on growth.

Focusing on niche areas of medical technology development allows German SMEs to react flexibly, meeting a broad range of demands and supplying highly specialised products.



ELMAT:Note that Germany will block foreign takeovers to avoid economy sell-out
reuters.com
The German gorvern ment do not want foreigners to come scoop their industry


One standout Berlin-based start-up is Ada Health. Ada has created an artificial intelligence (AI) powered health platform intended to support clinical decision making to help people around the world understand their health. Over ten million symptom assessments have been carried out using Ada, which has grown to over seven million users. Users are able to describe their symptoms to an AI powered symptom checker, which will then make a preliminary assessment for them to take to their GP. Ada has raised a total of $69.3m over three funding rounds.

Ada Health co-founder and CEO Daniel Nathrath says: “Germany is home to internationally recognised research and medical institutions, like the Max Plank Institute and Charité, has an extensive health ecosystem, and sets a high benchmark for rigorous technical standards. As a German-founded company headquartered in the country’s capital, we have access to a diverse talent pool and industry-leading tech expertise, which has been a real advantage to our business as we’ve expanded globally.”

Since its launch in 2016 after six years of research and development, Ada was won ten prestigious awards, including the Europas Hottest Health Start-up, a Silver Cannes Lions Award, and the AI for the Betterment of Humanity Prize.

World class educationGermany is home to three of the top 15 medical schools in Europe: Charité Universitätsmedizin Berlin, Ruprecht-Karls-Universität Heidelberg and Ludwig-Maximilians-Universität München.

Germany also has the second highest rate of students enrolling in technological fields in the EU, with 29% of university students studying science, mathematics, computer science or engineering. There are over 150 different bachelors and masters courses available throughout the country for students to choose from which specialise directly in medical technology.

Interdisciplinary vocational education programmes in the medical field are also offered by numerous colleges and technical schools in Germany for those who do not choose to pursue a university education. For many school leavers, heading straight to career in medical technology is highly appealing due to the broad range of occupations available in the industry. Apprenticeships are readily available at many of the country’s top med tech firms, in close collaboration with the German Chambers of Industry and Commerce and the German Confederation of Skilled Crafts.

Medical device companies in Germany actively seek to foster interest in their technology among young people, with many setting up their own interactive museums to reach out to children and make the prospect of working in the field as adults more attractive to them.

Innovation for the elderly
By 2035, Germany’s over-65 population will reach 24 million, representing a third of the domestic population, while the over-50 demographic will represent at least half. As such, digital health companies in Germany have become heavily focused on the ‘silver economy’, working on developing medical devices which will improve the quality of life for an aging population.

Keussen says: “Robotic support in geriatric care and digital applications for home care are unique challenges which are relevant for Germany as well as for other markets with a rapidly aging society, e.g. Japan, China and Scandinavia.”

There are more than 400 departments or hospitals in Germany dedicated to geriatric medicine, and since 2003 there has been a national obligation to include medicine of aging and the elderly in pre-graduate medical training.

Geriatric medtech in Germany is heavily focused on technologies which alert carers when their patients need assistane. Start-up AssistMe is working on developing adult incontinence underwear with a built in sensor to alert care staff when they need changing, while MOIO care has developed a set of sensors designed to be worn on a patients lower back. MOIO’s sensors have multiple functions, including fall alert, atypical motion alert, and GPS tracking.

Setting international standards
The German medical device market is subject to strict safety regulations, something which should give manufacturers considerable peace of mind in the wake of the worldwide failures in medical devices revealed in the Implant Files investigation.

German medical devices have to comply with the EU-wide regulations of the CE mark, which must be obtained for all devices sold with an intended medical purpose in Europe. Medical devices are not certified by governmental institutions in Europe but by organisations known as ‘notified bodies’ which operate on the government’s behalf.

There are ten notified bodies headquartered in Germany, meaning manufacturers have plenty of pathways open when assessing the safety of the equipment they produce.



To: Dr. Voodoo who wrote (4929)4/17/2020 3:40:07 AM
From: elmatador  Read Replies (1) | Respond to of 13800
 
Robert F. Kennedy Jr. Drops New Bombshell — Bill Gates’ Coronavirus Vaccine Will Pay Out BILLIONS in Profits to Dr. Fauci’s Agency

truepundit.com

Courtesy of Winfastorlose Message 32682739

If you are one of the millions of Americans wondering why Dr. Anthony Fauci is vehemently cheerleading and praising a coronavirus vaccine for ALL Americans … Robert F. Kennedy Jr. says follow the money.

Bobby Kennedy Jr. dropped a bombshell on the Thomas Paine Podcast, detailing an apparent agreement between the National Institute of Health (NIH) and the Bill Gates-backed pharmacuetical company that has the best chance at this point of securing lucrative contracts for a national coronavirus vaccine. (Listen at top)

That puts your government in bed with Big Pharma and Gates and could pay as much as 50 percent of the profits to the NIH, the parent agency that employs Dr. Anthony Fauci — who again — is lobbying for the vaccine. Does Fauci get a cut of the bounty too? Or has he already been cut in?

Federal officials are not commenting on Kennedy’s alarming information. But … the NIH is the key player in deciding what vaccines get approved for coronavirus and the NIH and government would profit wildly, as Kennedy said, if the Gates-backed pharma play Moderna Inc. gets the green light. Kennedy slammed both Gates and Fauci on numerous occasions during the exclusive interview with Paine. Gates’ company is already in human trials with the vaccine. Just weeks after the outbreak? Listen at top.